Cart is empty The past five years have seen significant advancements in diagnosing and treating multiple sclerosis (MS), but challenges remain—especially among patients who are living longer, a result of more effective treatments—according to a new paper published in The Lancet by University at Buffalo researchers.
Leave A Comment